Stendra (avanafil)

Company
Vivus

Approval Status
Approved April 2012

Treatment for
erectile dysfunction

Possible similar drugs
Stendra

Stendra (avanafil) phosphodiesterase 5 (PDE5) inhibitor. PDE5 is responsible for the degradation of cGMP, which produces smooth muscle relaxation in the corpus cavernosum and allows inflow of blood.

Stendra is specifically indicated for the treatment of erectile dysfunction.

Stendra is supplied as a tablet designed for oral administration. The recommended initial dose of Stendra is 100 mg taken approximately 30 minutes before sexual activity with or without food. The dose may be increased to 200 mg or decreased to 50 mg. Use the lowest dose that provides benefit on an as needed basis no more than once per day.

FDA Approval
The FDA approval of Stendra was based on the results of 3 randomized, double-blind, placebo-controlled, parallel group trials. The trials enrolled

Stendra_1201 Drug Information

The Stendra_1201 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top